These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19179433)

  • 1. Peroxisome-proliferator receptor gamma represses hepatic sex hormone-binding globulin expression.
    Selva DM; Hammond GL
    Endocrinology; 2009 May; 150(5):2183-9. PubMed ID: 19179433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4alpha.
    Selva DM; Hammond GL
    J Mol Endocrinol; 2009 Jul; 43(1):19-27. PubMed ID: 19336534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pal3 promoter sequence is critical for the regulation of human renin gene transcription by peroxisome proliferator-activated receptor-gamma.
    Todorov VT; Desch M; Schubert T; Kurtz A
    Endocrinology; 2008 Sep; 149(9):4647-57. PubMed ID: 18483152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome.
    Pugeat M; Nader N; Hogeveen K; Raverot G; Déchaud H; Grenot C
    Mol Cell Endocrinol; 2010 Mar; 316(1):53-9. PubMed ID: 19786070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands.
    Seimandi M; Lemaire G; Pillon A; Perrin A; Carlavan I; Voegel JJ; Vignon F; Nicolas JC; Balaguer P
    Anal Biochem; 2005 Sep; 344(1):8-15. PubMed ID: 16038868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium.
    Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R
    Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.
    Pellieux C; Montessuit C; Papageorgiou I; Lerch R
    Pflugers Arch; 2007 Dec; 455(3):443-54. PubMed ID: 17643263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAM3A is a target gene of peroxisome proliferator-activated receptor gamma.
    Zhou Y; Jia S; Wang C; Chen Z; Chi Y; Li J; Xu G; Guan Y; Yang J
    Biochim Biophys Acta; 2013 Aug; 1830(8):4160-70. PubMed ID: 23562554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Peroxisome Proliferator-Activated Receptor (PPAR)-
    Schubert M; Becher S; Wallert M; Maeß MB; Abhari M; Rennert K; Mosig AS; Große S; Heller R; Grün M; Lorkowski S
    Mol Pharmacol; 2020 Mar; 97(3):212-225. PubMed ID: 31871304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-gamma transcriptionally up-regulates hormone-sensitive lipase via the involvement of specificity protein-1.
    Deng T; Shan S; Li PP; Shen ZF; Lu XP; Cheng J; Ning ZQ
    Endocrinology; 2006 Feb; 147(2):875-84. PubMed ID: 16269451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones.
    Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
    Endocrinology; 2009 Feb; 150(2):862-70. PubMed ID: 19147680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor β/δ and γ agonists differentially affect prostaglandin E2 and cytokine synthesis and nutrient transporter expression in porcine trophoblast cells during implantation.
    Blitek A; Szymanska M
    Theriogenology; 2020 Aug; 152():36-46. PubMed ID: 32361305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-alpha and -gamma.
    Nie W; Sweetser S; Rinella M; Green RM
    Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G207-12. PubMed ID: 15458920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor γ ligands retard cultured vascular smooth muscle cells calcification induced by high glucose.
    Zhou YB; Zhang J; Peng DQ; Chang JR; Cai Y; Yu YR; Jia MZ; Wu W; Guan YF; Tang CS; Qi YF
    Cell Biochem Biophys; 2013 Jul; 66(3):421-9. PubMed ID: 23274912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor-alpha control of lipid and glucose metabolism in human white adipocytes.
    Ribet C; Montastier E; Valle C; Bezaire V; Mazzucotelli A; Mairal A; Viguerie N; Langin D
    Endocrinology; 2010 Jan; 151(1):123-33. PubMed ID: 19887568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHBG-C57BL/ksJ-db/db: A New Mouse Model to Study SHBG Expression and Regulation During Obesity Development.
    Saéz-López C; Rivera-Giménez M; Hernández C; Simó R; Selva DM
    Endocrinology; 2015 Dec; 156(12):4571-81. PubMed ID: 26441241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approach to treat insulin resistance, type 2 diabetes, and the metabolic syndrome: simultaneous activation of PPARalpha, PPARgamma, and PPARdelta.
    Evans JL; Lin JJ; Goldfine ID
    Curr Diabetes Rev; 2005 Aug; 1(3):299-307. PubMed ID: 18220606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
    Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
    Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.